Success in alliances and acquisitions is rare. Top executives focus – what, where and when. Developing such focus can take decades of trial, and error. Your company can ill afford errors. They delay benefits and divert resources.

Value-Inflection Points (VIPs) capture and systematize the experts’ ability to focus on what matters. They increase value, accelerate success, optimize investment and develop leaders. VIPs are now foundational at several dozen major pharmaceutical and biotechnology companies, as well as industries from mining to software development.

BTD is launching a 6-part podcast series to help executives find the moments that matter. In this podcast, join David S. Thompson, Global Head of Alliance Management at BeiGene Pharmaceuticals and HBR author, Tim O’Connor, Group Exploration Officer at BHP, and Dr. Victoria Dalton, internationally renowned executive coach. Along with your host, BTD Partner Nick Palmer, these VIP experts help you to understand and capitalize on VIPs in your companies.

The episodes cover the fundamental concepts. They go on to discuss using VIPs with your alliances and integrations.

• Identify VIPs for your deals.
• Manage complex initiatives using VIPs.
• Incorporate VIPs in your company’s strategy, design and implementation.
• Build alliance and integration teams that maximize the impact of VIPs.

These are intellectual journeys, not presentations. Learn from the executives who first codified and now lead the VIP revolution! Join us for the learning. Join us for inspiration. Join us for some fun.

Success in alliances and acquisitions is rare. Top executives focus – what, where and when. Developing such focus can take decades of trial, and error. Your company can ill afford errors. They delay benefits and divert resources.

Value-Inflection Points (VIPs) capture and systematize the experts’ ability to focus on what matters. They increase value, accelerate success, optimize investment and develop leaders. VIPs are now foundational at several dozen major pharmaceutical and biotechnology companies, as well as industries from mining to software development.

BTD is launching a 6-part podcast series to help executives find the moments that matter. In this podcast, join David S. Thompson, Global Head of Alliance Management at BeiGene Pharmaceuticals and HBR author, Tim O’Connor, Group Exploration Officer at BHP, and Dr. Victoria Dalton, internationally renowned executive coach. Along with your host, BTD Partner Nick Palmer, these VIP experts help you to understand and capitalize on VIPs in your companies.

The episodes cover the fundamental concepts. They go on to discuss using VIPs with your alliances and integrations.

• Identify VIPs for your deals.
• Manage complex initiatives using VIPs.
• Incorporate VIPs in your company’s strategy, design and implementation.
• Build alliance and integration teams that maximize the impact of VIPs.

These are intellectual journeys, not presentations. Learn from the executives who first codified and now lead the VIP revolution! Join us for the learning. Join us for inspiration. Join us for some fun.

One in two people will develop some form of cancer in their lifetimes. Despite decades of work, one-sixth of worldwide deaths are due to cancer. High-stakes research underpinned by strong alliances are making possible new therapies, bringing new hope.

In this podcast, Julie Little (Associate Director of Strategic Alliances) and Steve Wedge (Chief Scientific Officer) of Cancer Research UK discuss their organisation’s major role de-risking oncology research. CRUK has catalysed collaborations including biotech startups and big pharmaceutical companies alike. The newly formed Cancer Research Horizons will supercharge that mission.

BTD’s Nick Palmer leads the discussion. Learn more. Give it a listen.

#podcast #startups #biotech #research #oncology #pharmaceutical #alliances

A senior project, programme and integration professional, Louise Cooper joined the BTD team several years ago and has supported some of our largest and most complex engagements with clients such as Spectris and Glatfelter. In this podcast, Louise explores the differences between integration and more general transformation programmes, and what she finds challenging and fulfilling in her integration, separation and restructuring work.

www.btd.consulting
CLICK HERE to follow us on LinkedIn

All pharmaceutical companies look to leverage their capabilities to benefit those in the World’s poorest countries. Novartis aims to go beyond corporate philanthropy to create a more sustainable therapy-development model. By marshalling partnerships and its own people, Charlie Bailey leads Novartis teams pursuing development initiatives addressing better-known conditions like malaria, as well as more obscure ones like leishmaniasis. These initiatives can span a decade or more taking therapies through Phase I, II and III clinical trials, then ensuring the infrastructure and skills to offer them in the world’s most remote locations.

In this fascinating podcast, Charlie discusses the ideas behind Novartis’s access-focused product partnerships with BTD partner, Nick Palmer. Charlie explains how this new model offers a more sustainable path to addressing suffering in the Third World. Working with NGOs ranging from the Wellcome Trust and the Gates Foundation, to specialised ones like DNDi and MMV, Novartis is charting a course to bring First World therapies to the Third world, AND to push the boundaries of pharmaceutical innovation. He discusses specific examples and experiences to highlight this exciting approach.

CLICK HERE to follow us on LinkedIn
www.btd.consulting

John Palmer is a Senior Consultant who joined BTD in 2018, bringing his deep experience in business analysis and financial modelling to the team and our clients. John also leads our recruitment efforts and is pivotal in ensuring new team members – senior or junior – have the right skills, experience and values to join the BTD team. In this podcast, John shares his client experiences over the past few years and offers his view on what makes BTD, our team and our approach, different.

Barbara Vrdlovec joined BTD over ten years ago, and as our newest Director has seen almost every aspect of the business and our client work since then, supporting clients such as bwinParty, Glatfelter, and Innogy. She also leads our relationship with the Institute of Mergers, Acquisitions and Alliances (IMAA), providing training to groups worldwide. In this podcast, Barbara shares her view of how M&A and integration has changed over the past decade, what brought her to this field, and her hopes for the future of BTD.

Introducing our newest Partner and Head of our US practice, Nick Palmer. In this podcast, Nick discusses his 35 years in consulting and his approach to creating value for clients. Nick and Carlos discuss approaches and ideas that can help executives and aspiring consultants to be more effective. Having developed and led Strategy Training at Accenture, Nick shares actionable recommendations useful to all.

www.btd.consulting